Avinger announced this week it laid off 36 employees as part of a corporate restructuring. The image-guided atherectomy developer will shift the company’s strategic focus from manufacturing and selling products that treat peripheral artery disease (PAD) to developing image-guided devices that allow physicians to penetrate a total blockage in an artery. Avinger’s board of directors […]
Avinger
FDA clears Avinger’s Pantheris for in-stent restenosis
Avinger this week announced that it received FDA 510(k) clearance for a new clinical indication for its Pantheris image-guided atherectomy system. The new indication allows the Redwood City, California-based company to market the device for in-stent restenosis (ISR) treatment in the lower extremity arteries. Get the full story on our sister site, Medical Tubing + Extrusion.
Avinger reports Street-beating revenues in Q2
Avinger (NSDQ:AVGR) shares stood still this morning on second-quarter sales numbers that topped the consensus forecast. The Redwood City, Calif.-based image-guided catheter developer posted losses of -$3.5 million on sales of $2.8 million for the three months ended June 30, 2021, for a 43.1% bottom-line gain on sales growth of 9.5%. Earnings per share came […]
Avinger slides on mixed bag Q4 results
Avinger (NSDQ:AVGR) posted fourth-quarter results today that missed the earnings consensus on Wall Street but matched on sales. The Redwood City, Calif.-based company — maker of an image-guided, catheter-based peripheral artery disease treatment — reported losses of –$4.6 million, or –7¢ per share, on sales of $2.73 million for the three months ended Dec. 31, 2020, […]
Avinger looks to raise $3.15m
Avinger (NSDQ:AVGR) announced that it priced an underwritten public offering with expected gross proceeds of approximately $3.15 million. The offering includes 12.6 million shares of its treat peripheral artery disease treatment device developer Avinger’s common stock at 25¢ per share with Aegis Capital acting as the sole bookrunner. Redwood City, Calif.-based Avinger earmarked the potential proceeds […]
Avinger closes $5m offering
Avinger (NSDQ:AVGR) said yesterday that it closed a stock offering worth nearly $4.5 million for its line of devices designed to treat peripheral artery disease. The commercial-stage medical device company designs image-guided, catheter-based systems to diagnose and treat PAD. The closing of the equity offering came five days after the company priced the offering, as […]
Avinger prices $5m offering
Avinger (NSDQ:AVGR) yesterday priced a stock offering worth nearly $5 million for its line of devices to treat peripheral artery disease. The $4.5 million offering, of more than 3.8 million shares at $1.18 apiece, also includes a 45-day underwriters option on another 572,000 shares that would add $675,000 if exercised in full. The float is slated […]
Avinger pulls the trigger on 1-10 reverse split
Avinger (NSDQ:AVGR) last week pulled the trigger on a one-for-10 reverse stock split to boost its share price above the Nasdaq exchange’s $1-per-share minimum. The split took the number of outstanding shares from roughly 64.2 million to about 6.4 million, Redwood City, Calif.-based Avinger said. AVGR shares, which closed at 41.8¢ apiece June 21, jumped to […]
UPDATE: Avinger shares tumble on Q1 earnings miss
Updated to include market reaction. Shares in Avinger (NSDQ:AVGR) are falling today after the medical device maker posted first quarter earnings that missed Wall Street’s expectations for both losses per share and sales. The Redwood City, Calif.-based company posted losses of approximately $6 million, or 14¢ per share, on sales of $1.8 million for the three […]
Avinger wins FDA nod for Pantheris SV small vessel atherectomy device
Avinger (NSDQ:AVGR) said today that it won FDA 510(k) clearance for its Pantheris SV small vessel image-guided atherectomy system. The Pantheris SV is an extension of the Redwood City, Calif.-based company’s lumivascular image-guided atherectomy platform which it hopes will expand the available market for its Pantheris devices by up to 50%. The newly cleared device features a […]
Avinger shares rise despite Q4 earnings miss
Shares in Avinger (NSDQ:AVGR) have risen today despite the medical device maker posting fourth quarter earnings that missed expectations on Wall Street. The Redwood City, Calif.-based company posted losses of $6.9 million, or 31¢ per share, on sales of $2 million for the three months ended December 31, seeing losses shrink 31.8% while sales grew 6% […]
